The Global Antimicrobial Resistance Research and Development Hub – or Global AMR R&D Hub for short – is an initiative of international R&D funders to help combat antimicrobial drug resistance. The Hub was officially launched in 2018 at the request of the G20 state leaders. The aim of the Hub is to bring together and coordinate international research activities into resistant bacteria for humans, animals, plants and the environment.
As IT partner, adesso will develop the platform for the Hub, which will merge all information concerning AMR projects and investments and make it transparently available. The development and service contract, which adesso was awarded following a public tender, will run until the end of 2021.
The first milestone will be reached this spring with the public launch of a Dynamic Dashboard. This is set to provide an overview of the worldwide research activities and will be successively expanded.